Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EN
- Chemical substanceL01EN01Erdafitinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 4 registrations
Spain
AEMPS · 3 registrations
- Balversa 3 MG Comprimidos Recubiertos con Pelicula3 mg · comprimido recubierto con película · Janssen-Cilag International N.V
- Balversa 4 MG Comprimidos Recubiertos con Pelicula4 mg · comprimido recubierto con película · Janssen-Cilag International N.V
- Balversa 5 MG Comprimidos Recubiertos con Pelicula
At a glance
- ATC code
- L01EN01
- Registers
- 9
- Historical lists
- 1
- Registrations
- 22
- With their own page
- 20
- Companies
- 8
All medicines with Erdafitinib
Human medicines from every register that match Erdafitinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
22 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Balversa | United States | 3MG, 4MG, 5MG | tablet | Marketed | Janssen Biotech |
| Balversa | European Union | Authorised | Janssen-Cilag International N.V. | ||
| Balversa 3 MG Comprimidos Recubiertos con Pelicula | Spain | 3 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Balversa 4 MG Comprimidos Recubiertos con Pelicula | Spain | 4 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Balversa 5 MG Comprimidos Recubiertos con Pelicula | Spain | 5 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Erfandel | Brazil | Authorised | Janssen-Cilag Farmacêutica Ltda | ||
| Balversa 3 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa 4 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa 5 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa | Canada | 4 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 3 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 5 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 4 MG | Tablet | Authorised | Janssen INC |
| Balversa film-coated tablets 3mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa Film-Coated Tablets 3MG | Singapore | 3.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa Film-Coated Tablets 4MG | Singapore | 4.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa film-coated tablets 4mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa film-coated tablets 5mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa Film-Coated Tablets 5MG | Singapore | 5.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa | Croatia | Marketed | |||
| Balversa | Saudi Arabia | Authorised | Janssen-Cilag SPA | ||
| Erdafitinib | United States | tablet | Tentative approval | Natco Pharma LTD |